• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过使用小干扰RNA(siRNA)进行基因操作:从体外应用到体内应用。

Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications.

作者信息

Kumar Lekha Dinesh, Clarke Alan R

机构信息

Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500 007, India.

出版信息

Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):87-100. doi: 10.1016/j.addr.2007.03.009. Epub 2007 Mar 20.

DOI:10.1016/j.addr.2007.03.009
PMID:17434644
Abstract

The conventional approach to investigate genotype-phenotype relationships has been the generation of gene targeted murine strains. However, the emergence of RNAi technologies has opened the possibility of much more rapid (and indeed more cost effective) genetic manipulation in vivo at the level of the transcriptome. Successful application of RNAi in vivo depends on intracellular targeted delivery of siRNA/shRNA molecules for efficient knockdown of the desired gene. In this review, we discuss the rationale and different strategies of using siRNA/shRNA for accomplishing the silencing of targeted genes in a spatial and /or temporally regulated manner. We also summarise the steps involved in extending these approaches to in vivo applications, with a specific focus upon the development of silencing in the mouse.

摘要

研究基因型与表型关系的传统方法是构建基因靶向小鼠品系。然而,RNA干扰技术的出现为在转录组水平上更快速(且确实更具成本效益)地进行体内基因操作开辟了可能性。RNA干扰在体内的成功应用取决于将小干扰RNA/短发夹RNA分子进行细胞内靶向递送,以有效敲低所需基因。在本综述中,我们讨论了使用小干扰RNA/短发夹RNA以空间和/或时间调控方式实现靶向基因沉默的基本原理和不同策略。我们还总结了将这些方法扩展到体内应用所涉及的步骤,特别关注在小鼠体内实现基因沉默的发展情况。

相似文献

1
Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications.通过使用小干扰RNA(siRNA)进行基因操作:从体外应用到体内应用。
Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):87-100. doi: 10.1016/j.addr.2007.03.009. Epub 2007 Mar 20.
2
Mammalian RNAi: a practical guide.哺乳动物RNA干扰:实用指南。
Biotechniques. 2005 Aug;39(2):215-24. doi: 10.2144/05392RV01.
3
In vivo application of RNA interference: from functional genomics to therapeutics.RNA干扰的体内应用:从功能基因组学到治疗学
Adv Genet. 2005;54:117-42. doi: 10.1016/S0065-2660(05)54006-9.
4
The design and exogenous delivery of siRNA for post-transcriptional gene silencing.用于转录后基因沉默的小干扰RNA(siRNA)的设计与外源递送。
J Drug Target. 2004 Jul;12(6):315-40. doi: 10.1080/10611860400006257.
5
Efficient and targeted delivery of siRNA in vivo.体内 siRNA 的高效和靶向递送。
FEBS J. 2010 Dec;277(23):4814-27. doi: 10.1111/j.1742-4658.2010.07904.x.
6
Functional nanostructures for effective delivery of small interfering RNA therapeutics.用于有效递送小干扰RNA疗法的功能性纳米结构。
Theranostics. 2014 Sep 19;4(12):1211-32. doi: 10.7150/thno.8491. eCollection 2014.
7
Targeted delivery systems of small interfering RNA by systemic administration.通过全身给药实现小干扰RNA的靶向递送系统
Drug Metab Pharmacokinet. 2007 Jun;22(3):142-51. doi: 10.2133/dmpk.22.142.
8
Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.用于RNA干扰的非病毒药物递送系统的毒理基因组学:对小干扰RNA介导的基因沉默活性和特异性的潜在影响。
Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):164-82. doi: 10.1016/j.addr.2007.03.010. Epub 2007 Mar 21.
9
Nonviral in vivo delivery of therapeutic small interfering RNAs.治疗性小干扰RNA的非病毒体内递送
Curr Opin Mol Ther. 2007 Aug;9(4):345-52.
10
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development.利用体内小干扰RNA递送技术进行药物发现和治疗开发。
Drug Discov Today. 2006 Jan;11(1-2):67-73. doi: 10.1016/S1359-6446(05)03668-8.

引用本文的文献

1
Engineered extracellular vesicles carrying let-7a-5p for alleviating inflammation in acute lung injury.携带 let-7a-5p 的工程细胞外囊泡可减轻急性肺损伤中的炎症。
J Biomed Sci. 2024 Mar 19;31(1):30. doi: 10.1186/s12929-024-01019-4.
2
Causes of and Molecular Targets for the Treatment of Intervertebral Disc Degeneration: A Review.治疗椎间盘退变的病因和分子靶点:综述。
Cells. 2022 Jan 24;11(3):394. doi: 10.3390/cells11030394.
3
Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects.用于阻塞性气道疾病的吸入式RNA疗法:最新进展与未来前景
Pharmaceutics. 2021 Jan 28;13(2):177. doi: 10.3390/pharmaceutics13020177.
4
Organic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myeloid Leukemia.有机纳米颗粒作为药物传递系统及其在治疗慢性髓性白血病中的潜在作用。
Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819879902. doi: 10.1177/1533033819879902.
5
Pathways of cellular internalisation of liposomes delivered siRNA and effects on siRNA engagement with target mRNA and silencing in cancer cells.脂质体递送的 siRNA 的细胞内化途径及其对 siRNA 与靶 mRNA 结合和癌细胞沉默的影响。
Sci Rep. 2018 Feb 28;8(1):3748. doi: 10.1038/s41598-018-22166-3.
6
Knockdown of Progesterone Receptor (PGR) in Macaque Granulosa Cells Disrupts Ovulation and Progesterone Production.猕猴颗粒细胞中孕酮受体(PGR)的敲低会破坏排卵和孕酮生成。
Biol Reprod. 2016 May;94(5):109. doi: 10.1095/biolreprod.115.134981. Epub 2016 Mar 16.
7
Lipid-Based Nanocarriers for RNA Delivery.用于RNA递送的脂质基纳米载体
Curr Pharm Des. 2015;21(22):3140-7. doi: 10.2174/1381612821666150531164540.
8
Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.纳米毒性:基于小干扰RNA的纳米药物临床转化的关键障碍。
Nanomedicine (Lond). 2014 Feb;9(2):295-312. doi: 10.2217/nnm.13.204.
9
Spindle and kinetochore associated complex subunit 1 regulates the proliferation of oral adenosquamous carcinoma CAL-27 cells in vitro.纺锤体和着丝粒相关复合物亚基 1 调节体外口腔腺样囊性癌 CAL-27 细胞的增殖。
Cancer Cell Int. 2013 Aug 20;13(1):83. doi: 10.1186/1475-2867-13-83.
10
RNA therapeutics targeting osteoclast-mediated excessive bone resorption.针对破骨细胞介导的过度骨吸收的 RNA 治疗。
Adv Drug Deliv Rev. 2012 Sep;64(12):1341-57. doi: 10.1016/j.addr.2011.09.002. Epub 2011 Sep 10.